logo
Scientists deploy ‘mosquito STD' to fight malaria in bold biotech breakthrough

Scientists deploy ‘mosquito STD' to fight malaria in bold biotech breakthrough

Yahoo05-06-2025
Scientists have flipped the script on mosquitoes, turning their mating rituals into a lethal weakness.
In a striking twist on pest control, researchers have engineered a sexually transmitted fungus that strikes during sex, infecting and killing mosquitoes from within.
This microscopic assassin offers fresh hope in the fight against malaria, a disease that kills more than 600,000 people each year, most of them young children in sub-Saharan Africa.
The fungus targets female mosquitoes, the ones that bite and spread the disease, delivering a fatal blow at the moment they mate.
And unlike chemical sprays or bed nets, which mosquitoes have learned to dodge, this approach hijacks their most basic instinct—ensuring the fungus spreads naturally, one deadly encounter at a time.
'It's essentially an arms race between the mosquitoes and us,' said study co-author Raymond St. Leger, a university professor of Entomology at the University of Maryland, in a release.
'Just as they keep adapting to what we create, we have to continuously develop new and creative ways to fight them.'Mosquitoes' remarkable ability to adapt has long frustrated disease-control efforts. As indoor repellents like bed nets and insecticide sprays improved, mosquitoes shifted tactics, moving outdoors and striking at new times to avoid human defenses.
To counter these evasive pests, the team enhanced a naturally occurring fungus called Metarhizium, equipping it to produce insect-specific neurotoxins that kill once inside a female mosquito's body.
Instead of direct application, the fungus rides into action via infected male mosquitoes, which are dusted with fungal spores and released. When they mate, they pass the killer fungus directly to their partners.
In real-world field trials in Burkina Faso, nearly 90 percent of female mosquitoes that mated with fungus-laden males died within two weeks compared to just 4 percent in the control group.
Crucially, while deadly to mosquitoes, the modified Metarhizium poses no threat to humans.
'What makes this fungus particularly promising is that it works with existing mosquito behavior rather than against their natural habits,' St. Leger said.
'Unlike pesticides or other chemical control methods that mosquitoes can develop resistance to, this method uses the mosquitoes' own biology to deliver the control agent.'
Researchers also discovered that infected males could continue transmitting the fungus for up to 24 hours after initial exposure, enabling each male to infect multiple females over time.
'Interestingly, we noticed that the presence of the fungus did not deter female mosquitoes from mating with infected males. Mating rates stayed the same, which makes this fungus a very powerful mosquito population control tool,' St. Leger said. 'And the fungus additionally made infected mosquitoes less able to sense insecticides, and much more susceptible to them, so it's really a double blow against them.'
With Metarhizium already widely used in agriculture for pest control, scientists believe this mosquito-specific adaptation could be a game changer, especially when paired with existing methods.
While hurdles remain to scale up the 'mosquito STD' for widespread use, the study marks a major leap forward in the long battle against mosquito-borne diseases.
'Mosquitoes are the world's deadliest animal. It's believed that they alone, by transmitting disease, have killed half of all human beings who have ever lived,' St. Leger noted. 'Being able to eliminate mosquitoes quickly and effectively will save people all over the world.'
The study has been published in Scientific Reports.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US pediatricians' new COVID-19 shot recommendations differ from CDC advice
US pediatricians' new COVID-19 shot recommendations differ from CDC advice

Boston Globe

timea day ago

  • Boston Globe

US pediatricians' new COVID-19 shot recommendations differ from CDC advice

'It is going to be somewhat confusing. But our opinion is we need to make the right choices for children to protect them,' he added. The AAP is strongly recommending COVID-19 shots for children ages 6 months to 2 years. Shots also are advised for older children if parents want their kids vaccinated, the AAP said. Advertisement That differs from guidance established under US Health Secretary Robert F. Kennedy Jr., which doesn't recommend the shots for healthy children of any age but says kids may get the shots in consultation with physicians. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up Children ages 6 months to 2 years are at high risk for severe illness from COVID-19, and it was important that recommendations continue to emphasize the need for them to get vaccinated, said Campbell, a University of Maryland infectious diseases expert. Vaccinations also are recommended for older children who have chronic lung diseases or other conditions that put them at higher risk for severe disease, the AAP said. In a statement, Department of Health and Human Services spokesperson Andrew Nixon said 'the AAP is undermining national immunization policymaking with baseless political attacks.' He accused the group of putting commercial interests ahead of public health, noting that vaccine manufacturers have been donors to the AAP's Friends of Children Fund. The fund is currently paying for projects on a range of topics, including health equity and prevention of injuries and deaths from firearms. Advertisement The 95-year-old Itasca, Illinois-based organization has issued vaccination recommendations for children since the 1930s. In 1995, it synced its advice with recommendations made by the federal government's Centers for Disease Control and Prevention. There have been a few small differences between AAP and CDC recommendations since then. For example, the AAP has advised that children get HPV vaccinations starting at age 9; the CDC says that's OK but has emphasized vaccinations at ages 11 and 12. But in 30 years, this is the first time the recommendations have differed 'in a significant or substantial way,' Campbell said. Until recently, the CDC — following recommendations by infectious disease experts — has been urging annual COVID-19 boosters for all Americans ages 6 months and older. But in May, US Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. A few days later, the CDC issued language that healthy children may get the shots, but that there was no longer a 'should' recommendation. The idea that healthy older kids may be able to skip COVID-19 boosters has been brewing for some time among public health experts. As the COVID-19 pandemic has waned, experts have increasingly discussed the possibility of focusing vaccination efforts on people 65 and older — who are among those most as risk for death and hospitalization. A CDC expert panel in June was set to make recommendations about the fall shots. Among the options the panel was considering was whether suggest shots for high-risk groups but still giving lower-risk people the choice to get vaccinated. Advertisement But Kennedy bypassed the group, and also decided to dismiss the 17-member panel and appoint his own, smaller panel, that included vaccine skeptics. Kennedy also later excluded the AAP, the American Medical Association and other top medical organizations from working with the advisers to establish vaccination recommendations. Kennedy's new vaccine panel has yet to vote on COVID-19 shot recommendations. The panel did endorse continuing to recommend fall flu vaccinations, but also made a decision that led to another notable difference with the AAP. The new advisory panel voted that people should only get flu vaccines that are packaged as single doses and do not contain the preservative thimerosal. The AAP said there is no evidence of harm from the preservative, and recommended doctors use any licensed flu vaccine product that's appropriate for the patient.

Scientists make concerning discovery after analyzing melted glaciers: 'An important future question'
Scientists make concerning discovery after analyzing melted glaciers: 'An important future question'

Yahoo

time09-08-2025

  • Yahoo

Scientists make concerning discovery after analyzing melted glaciers: 'An important future question'

Scientists make concerning discovery after analyzing melted glaciers: 'An important future question' For years, scientists have monitored the close relationship between rising carbon pollution and the melting of glaciers in the Arctic. According to a new study from researchers from the University of Florida and the University of Maryland, there may be a new dimension to the relationship that requires a closer look. What's happening? As noted in the study, the team of researchers theorized that as glaciers melt and uncover land, the fresh sediments first trigger chemical reactions that actually help suppress greenhouse gases. The team explained its findings in an article published by Jonathan Martin, a professor of geological sciences at UF and the lead author of the study, revealed the core principle behind the research. "Our central hypothesis was that the transfer of greenhouse gases between landscapes and the atmosphere has changed since the Last Glacial Maximum about 15,000 years ago, as the landscapes are exposed following loss of continental ice sheets," noted Martin. To test this theory, the team conducted field research at a "partially deglaciated watershed" in southwest Greenland. It was able to collect fresh glacial meltwater samples that contained low concentrations of reactive dissolved organic carbon. The researchers also pulled soil water that had been exposed to atmospheric conditions since the glacier first began retreating thousands of years ago. Why is this glacier study important? When newly crushed rock from melting glaciers breaks down through chemical reactions, it pulls carbon dioxide out of the air and stores it. This helps reduce the amount of greenhouse gases released into the atmosphere, at least temporarily. The team suggests that the meltwater was reacting with the fine, crushed rock left behind by the moving glaciers, which helped limit greenhouse gas release at first. But over thousands of years, as soil started to form on the exposed land, new chemical reactions began. These reactions in the soil started to produce methane, another powerful greenhouse gas. "These results imply that the loss of carbon dioxide from the atmosphere during deglaciation after the Last Glacial Maximum reduced the heat-trapping capacity of the atmosphere and provided a negative feedback on natural global warming associated with the transition out of an ice age," explained Martin. The increase in global temperature has significantly impacted the environment by causing shifts in weather patterns, rising sea levels, disruptions to ecosystems, and other critical climate issues. These changes lead to more frequent and intense extreme weather events that threaten both wildlife and human populations. What's being done about carbon emissions? The researchers believe that the exposed land ultimately produced more methane. Since methane is a strong greenhouse gas, this would make the atmosphere better at trapping heat, which in turn would lead to the continued increase of the global temperature. While researchers have detailed the impacts of gases like methane and carbon dioxide, Martin is now eyeing a new study that focuses more on nitrous oxide. Even though nitrous oxide represents just 6% of all gas emissions, its ability to trap heat in the atmosphere hasn't gone unnoticed. "An important future question would be to evaluate how the relative magnitudes of production and loss of these three greenhouse gases relate to each other to regulate warming and cooling during the loss of glacial ice," Martin added. Do you worry about the longevity of EV batteries? For sure Not really Not at all I've never thought about it Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword

Synthetic, shelf-stable blood developed by Maryland scientist could save lives in emergencies
Synthetic, shelf-stable blood developed by Maryland scientist could save lives in emergencies

CBS News

time04-08-2025

  • CBS News

Synthetic, shelf-stable blood developed by Maryland scientist could save lives in emergencies

A Maryland scientist developed synthetic blood that could save lives when seconds count and fresh blood is out of reach. Dr. Allan Doctor is a professor-scientist at the University of Maryland School of Medicine. He is developing a shelf-stable, synthetic blood product that he calls ArithroMir. The blood alternative could be used in the field without a refrigerator or a donor match, he said. ArithroMir is a powder-based product that, when mixed with water, transforms into a liquid that can deliver oxygen to tissues in trauma situations. "Thirty thousand people every year in the U.S. bleed to death before they can get to a hospital," Doctor said. "We can't give transfusions in the field right now. Imagine if we couldn't give oxygen in the field." Doctor and his team have tested the product in animals, successfully replacing up to 90% of their blood volume with the synthetic version. ArithroMir is a freeze-dried powder that contains hemoglobin, the oxygen-carrying component of blood extracted and stabilized outside of red blood cells. The innovation is not intended to replace traditional blood donations. Instead, Doctor describes it as a "bridging therapy" meant to stabilize patients long enough to reach a hospital where natural blood is available. "It doesn't have all the enzymes that natural red cells have," Doctor said. "It's really designated for resuscitation only." One notable advantage is that ArithroMir is a universal donor product. It can be given to any blood type and, remarkably, to any species, making it potentially useful for both humans and animals. Doctor hopes that human trials will begin within two years. If approved by the Food and Drug Administration (FDA), the synthetic blood could be available commercially within the next five to eight years. Experts believe the technology could prove invaluable for paramedics, the military, and even future space missions where access to traditional blood transfusions is not possible.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store